- 233 - 273. 274. 275. 276. 277. 278. 279. 280. 281. 282. 283. 284. 285. 286. 287. accompanying substances, with the total mass) 5-APDB 0.05-0.25 (3-desoxy-MDA, ЕМА-4) 5-(2-aminopropyl)-2,3-dihydrobenzofuran (irrespective of the existence of accompanying substances, with the total mass) 6-APDB 0.05-0.25 (4-desoxy-MDA, ЕМА-3) 6 - (2-aminopropyl) -2,3-dihydrobenzofuran (irrespective of the existence of accompanying substances, with the total mass) DOI 0.05-0.25 2,5-Dimethoxy-4-iodoamphetamine (irrespective of the existence of accompanying substances, with the total mass) (point repealed by HO-204-N of 20 October 2016) 25B-NBOMe [2-(4-bromo-2,5-dimethoxyphenyl)-N-]- (2- 0.05-0.25 methoxyphenyl)-methyl]ethanamine 25B-NBOMe-Nme [2-(4-bromo-2,5- dimethoxyphenyl)-ethyl]- 0.05-0.25 (2- methoxybenzyl)-methylamine 25B-NBOMeTF [2-(4-bromo-2,5-dimethoxyphenyl)-ethyl]-(2- 0.05-0.25 trifluoromethoxybenzyl)-amine 25C-NBOMe 2-(4-chloro-2,5-dimethoxyphenyl)-N-(20.05-0.25 methoxybenzyl)ethanamine 25H-NBOMe [2-(2,5-dimethoxyphenyl)-ethyl]-(20.05-0.25 methoxybenzyl)-amine JWH-213 (5-ethylnaphthalene-1-yl)-(2-methyl-1-pentyl- 0.05-0.25 1H-indole-3-yl)-methanone ACBM(N)-2201 TMS N-((3s,5s,7s)-adamantane-1-yl)-1-(50.05-0.25 fluoropentyl)-N-(trimethylsilyl)-1H-indazole-3carboxamide MBA(N)-BZ-F (AB-FUBINACA) N-(1-carbamoyl-2-methylprop-1-yl)-1- (4- 0.05-0.25 fluorobenzyl)-1H-indazole-3-carboxamide MBA(N)-018 (AB-PINACA) N-(1-carbamoyl-2-methylprop-1-yl)-1-pentyl- 0.05-0.25 1H-indazole-3-carboxamide MBA(N)-018 (AB-PINACA)-N-(2fluoropentyl) 0.05-0.25 1-(2-fluoropentyl)-1H-indazole-3-carboxylic acid (1-carbamoyl-2-methylpropyl)-amide MBA(N)-018 (AB-PINACA)-N-(40.05-0.25 fluoropentyl) CDL-REF(2021)022 0.25-0.5 0.5 0.25-0.5 0.5 0.25-0.5 0.5 0.25-0.5 0.5 0.25-0.5 0.5 0.25-0.5 0.5 0.25-0.5 0.5 0.25-0.5 0.5 0.25-0.5 0.5 0.25-0.5 0.5 0.25-0.5 0.5 0.25-0.5 0.5 0.25-0.5 0.5 0.25-0.5 0.5

Select target paragraph3

Connect to a paragraph
Connect to an entity
Disable highlights
Add to table of contents